DK0463877T3 - Farmaceutisk præparat med kontrolleret frigivelse - Google Patents

Farmaceutisk præparat med kontrolleret frigivelse

Info

Publication number
DK0463877T3
DK0463877T3 DK91305834.3T DK91305834T DK0463877T3 DK 0463877 T3 DK0463877 T3 DK 0463877T3 DK 91305834 T DK91305834 T DK 91305834T DK 0463877 T3 DK0463877 T3 DK 0463877T3
Authority
DK
Denmark
Prior art keywords
controlled release
release pharmaceutical
water
medicinal compound
preparation
Prior art date
Application number
DK91305834.3T
Other languages
Danish (da)
English (en)
Inventor
Kazuo Noda
Takashi Osawa
Masao Kobayashi
Shigeyuki Ishikawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26494375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0463877(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of DK0463877T3 publication Critical patent/DK0463877T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pens And Brushes (AREA)
  • Surgical Instruments (AREA)
  • Stringed Musical Instruments (AREA)
DK91305834.3T 1990-06-28 1991-06-27 Farmaceutisk præparat med kontrolleret frigivelse DK0463877T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17176290 1990-06-28
SG4995A SG4995G (en) 1990-06-28 1995-01-13 Controlled release pharmaceutical preparation

Publications (1)

Publication Number Publication Date
DK0463877T3 true DK0463877T3 (da) 1994-06-27

Family

ID=26494375

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91305834.3T DK0463877T3 (da) 1990-06-28 1991-06-27 Farmaceutisk præparat med kontrolleret frigivelse

Country Status (17)

Country Link
US (1) US5137733A (hu)
EP (1) EP0463877B2 (hu)
JP (1) JP2558396B2 (hu)
KR (1) KR0133511B1 (hu)
CN (1) CN1040061C (hu)
AT (1) ATE106241T1 (hu)
CA (1) CA2045358C (hu)
DE (1) DE69102211T3 (hu)
DK (1) DK0463877T3 (hu)
ES (1) ES2055962T5 (hu)
FI (1) FI103476B1 (hu)
GR (1) GR3024471T3 (hu)
HK (1) HK33895A (hu)
HU (1) HU214590B (hu)
IE (1) IE64629B1 (hu)
IL (1) IL98611A (hu)
SG (1) SG4995G (hu)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5286493A (en) * 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US7070806B2 (en) 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
CN1053808C (zh) * 1993-04-24 2000-06-28 章修纲 尼非地平控释剂型
JP2916978B2 (ja) * 1993-08-25 1999-07-05 エスエス製薬株式会社 放出開始制御型製剤
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
EP1009387B1 (en) 1997-07-02 2006-04-12 Euro-Celtique S.A. Stabilized sustained release tramadol formulations
KR20010040819A (ko) 1998-02-10 2001-05-15 가마꾸라 아끼오 제어방출형 제제
FR2778848B1 (fr) * 1998-05-20 2001-11-23 Prographarm Lab Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
US20010055613A1 (en) 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
US6270805B1 (en) 1998-11-06 2001-08-07 Andrx Pharmaceuticals, Inc. Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
US6039979A (en) * 1999-01-13 2000-03-21 Laboratoires Prographarm Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation
US6733789B1 (en) 1999-01-21 2004-05-11 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
JP2002535271A (ja) * 1999-01-21 2002-10-22 エラン コーポレーシヨン ピーエルシー 多粒子ビソプロロール製剤
GEP20053427B (en) 1999-12-23 2005-01-25 Pfizer Prod Inc Pharmaceutical Compositions Providing Enhanced Drug Concentrations
JP4100910B2 (ja) * 1999-12-23 2008-06-11 ファイザー・プロダクツ・インク ヒドロゲル駆動の薬物剤形
US20040185099A1 (en) * 2000-01-20 2004-09-23 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
US6620439B1 (en) * 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
US6984402B2 (en) 2000-10-03 2006-01-10 Elite Laboratories, Inc. Chrono delivery formulations and method of treating atrial fibrillation
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
AU2002339378A1 (en) * 2001-05-22 2002-12-03 Euro-Celtique Compartmentalized dosage form
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US20030118652A1 (en) * 2001-11-15 2003-06-26 John Kelly Methods and compositions for use of (S)-bisoprolol
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
US6663888B2 (en) 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US20050025824A1 (en) * 2001-12-14 2005-02-03 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
WO2004081054A1 (ja) * 2003-03-11 2004-09-23 Seikagaku Corporation 光架橋多糖組成物およびその製造方法
AU2004231362B2 (en) 2003-04-24 2009-11-12 Jagotec Ag Delayed release tablet with defined core geometry
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
WO2005107827A1 (ja) * 2004-05-07 2005-11-17 Seikagaku Corporation 髄核充填剤
DE102004043863A1 (de) 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
CA2591247A1 (en) * 2004-12-09 2006-06-15 Celgene Corporation Treatment of patients suffering from a disease having a family history or diagnosis of tics or tourette's syndrome with d-threo methylphenidate
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US8846100B2 (en) * 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
ES2400446T5 (es) 2006-08-03 2017-03-13 Horizon Pharma Ag Tratamiento con glucocorticoides de liberación retardada de una enfermedad reumática
JP2008024708A (ja) * 2007-08-20 2008-02-07 Euro-Celtique Sa アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
PL2358360T3 (pl) * 2008-11-18 2017-02-28 Ucb Biopharma Sprl Preparaty o przedłużonym uwalnianiu zawierające pochodną 2-okso-1-pirolidyny
CN101904813A (zh) * 2009-04-22 2010-12-08 苏维拉克皮肤及健康护理公司 冻干包衣的模制品
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
EP2647648B1 (en) * 2010-12-03 2017-08-09 Nippon Soda Co., Ltd. Solid dosage form containing a low viscosity HYDROXYALKYL CELLULOSE
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
EP4011364B1 (en) 2011-03-23 2023-12-13 Ironshore Pharmaceuticals & Development, Inc. Methods and compositions for treatment of attention deficit disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
JP5146859B2 (ja) * 2011-07-11 2013-02-20 ユーロ−セルティーク エス．エイ． アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944311A (ja) * 1982-09-07 1984-03-12 Santen Pharmaceut Co Ltd 徐放性顆粒およびその製造法
US5002776A (en) * 1983-12-22 1991-03-26 Elan Corporation, Plc Controlled absorption diltiazem formulations
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
US4559225A (en) * 1984-02-16 1985-12-17 Fourman Robert G Sunscreen composition
JPH0621066B2 (ja) * 1984-03-14 1994-03-23 杏林製薬株式会社 ３―イソブチリル―２―イソプロピルピラゾロ〔１，５―ａ〕ピリジンの徐放性医薬品組成物
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
ATE79029T1 (de) * 1989-02-11 1992-08-15 Bayer Ag Arzneimittel mit kontrollierter wirkstoffabgabe.
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings
US5013557A (en) * 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法

Also Published As

Publication number Publication date
GR3024471T3 (en) 1997-11-28
FI103476B (fi) 1999-07-15
HK33895A (en) 1995-03-17
HU214590B (hu) 1998-04-28
DE69102211T3 (de) 1997-08-28
EP0463877B2 (en) 1997-07-02
EP0463877B1 (en) 1994-06-01
CN1040061C (zh) 1998-10-07
KR0133511B1 (ko) 1998-04-23
ATE106241T1 (de) 1994-06-15
CA2045358C (en) 1998-04-28
IE912166A1 (en) 1992-01-01
SG4995G (en) 1995-06-16
IL98611A0 (en) 1992-07-15
FI912952A0 (fi) 1991-06-18
HUT59321A (en) 1992-05-28
ES2055962T3 (es) 1994-09-01
FI103476B1 (fi) 1999-07-15
ES2055962T5 (es) 1997-09-16
CN1058533A (zh) 1992-02-12
JPH04235123A (ja) 1992-08-24
HU912170D0 (en) 1991-12-30
EP0463877A1 (en) 1992-01-02
KR920000313A (ko) 1992-01-29
IL98611A (en) 1998-10-30
FI912952A (fi) 1991-12-29
CA2045358A1 (en) 1991-12-29
DE69102211D1 (de) 1994-07-07
IE64629B1 (en) 1995-08-23
AU634400B2 (en) 1993-02-18
US5137733A (en) 1992-08-11
DE69102211T2 (de) 1994-09-15
JP2558396B2 (ja) 1996-11-27
AU7924391A (en) 1992-01-02

Similar Documents

Publication Publication Date Title
DK0463877T3 (da) Farmaceutisk præparat med kontrolleret frigivelse
ATE53490T1 (de) Arzneipraeparate mit geregelter wirkstoffabgabe.
ATE92312T1 (de) Pharmazeutische zubereitung mit verzoegerter freisetzung und seine herstellung.
ATE67408T1 (de) Arzneimittel mit verzoegerter freigabe in oraler dosisform.
DE69323428T2 (de) Morphinzubereitungen mit kontrollierter freisetzung
ES2001897A6 (es) Procedimiento para la fabricacion de una tableta de liberacion controlada
DE69624047D1 (de) Im unteren Teil des Verdauungstrakts freisetzende pharmazeutische Zubereitung in Form einer beschichteten Kapsel
ATE68343T1 (de) Darreichungsform mit kontrollierter freigabe.
DE68913979D1 (de) Kationenaustauscherharze und carboxylgruppenhaltige Kunstharze enthaltende Arzneizubereitungen mit verzögerter Wirkstofffreisetzung.
DE69121465D1 (de) Mit Polyäthylenimin in-line beschichteter Polymerfilm
FI973107A0 (fi) Hallitusti vapautuvat vesiympäristön ravintoaineet
DE3788579T3 (de) Ferromagnetischer dünner Film und ihn verwendender Magnetkopf.
DE3889711D1 (de) Oberflächenbehandlung eines PET-Filmes.
ATA200091A (de) Kuenstlicher badeteich
BR8705086A (pt) Remanejo e retencao da enchente com liberacao-controlada da agua
IL100529A0 (en) Chiral polymers,their preparation and their application in the preparation of optically active 2-arylpropionic acids
ITRM910522A1 (it) Procedimento per la preparazione di un preparato cosmetico e/o farmaceutico in forma di pellicola spugnosa idrosolubile, e pellicola spugnosa idrosolubile cosi' ottenibile
IT8912614A0 (it) Barriera permeabile per i litorali marini atta a filtrare ed ossigenare le acque adiacenti
BA97198A (bs) 4-Okso-azetidin-2-sulfonske kiseline i soli metode priprave i upotreba
DE59006094D1 (de) Platte mit einer weissen und einer farbigen Schicht zur Herstellung eines Reliefbildes.